Skip to main content
. 2014 Apr 17;2014(1):5. doi: 10.1186/1687-9856-2014-5

Table 2.

Three years evolution in GnRHa treated and untreated patients with CPP

 
 Baseline
 1 yr
 2 yrs
 3 yrs
  Treated Untreated Treated Untreated Treated Untreated Treated Untreated After Tx
CA (yr)
 7.3 ± 1.5
 7.7 ± 0.7
 8.3 ± 1.5
 8.7 ± 0.9
 9.2 ± 1.5
 9.6 ± 0.7
 10.1 ± 1.5
 10.7 ± 1.2
 11.04 ± 0.4
Weight (z-score)
 1.4 ± 0.7
 1.2 ± 0.8
 1.4 ± 0.6
 1.3 ± 0.8
 1.3 ± 0.9
 1.2 ± 0.7
 1.6 ± 0.6*
 0.9 ± 0.5
 0.8 ± 0.9
BMI (z-score)
 1.2 ± 0.9
 1 ± 0.8
 1.2 ± 0.7
 1.1 ± 0.8
 1.1 ± 1
 1 ± 0.7
 1.3 ± 0.8
 0.7 ± 0.5
 0.7 ± 0.9
Ob/over (%)
 79.3
 50
 65.4
 50
 65.4
 50
 81.8
 40
 40
Obesity (%)
 24.1
 25
 26.9
 25
 23.1
 25
 45.5
 0
 20
Overweight (%)
 55.2
 25
 38.5
 25
 42.3
 25
 36.4
 40
 20
Glycemia (mg/dl)
 73.1 ± 9.1
 74 ± 7.6
 79.6 ± 8.9
 88.6 ± 6.5
 76 ± 10.1
 84.3 ± 11.7
 84.4 ± 5.3
 80 ± 2.6
 81 ± 18.4
Total-C (mg/dl)
 156 ± 31.5
 167.6 ± 35.7
 172.1 ± 34.8
 146.5 ± 42.3
 152.8 ± 38.6
 177.3 ± 23.9
 159.2 ± 26.5
 171.7 ± 39.1
 167.3 ± 19.4
LDL-C (mg/dl)
 96.6 ± 38.1
 99.5 ± 16.3
 108.1 ± 19.1
 71.3 ± 24.1
 92.9 ± 30.5
 112.5 ± 7.8
 100.2 ± 22.8
 128.8 ± 13.9
 122.5 ± 2.1
HDL-C (mg/dl)
 43.8 ± 9
 52 ± 7.1
 35 ± 10.1
 37.3 ± 9
 48.5 ± 12.8
 37 ± 4.2
 43.8 ± 14
 45.5 ± 2.1
 44.5 ± 14.9
TRG (mg/dl)
 83.3 ± 36.2
 115.8 ± 78.5
 80.9 ± 30.7
 90.8 ± 33.7
 79.9 ± 46.5
 117 ± 66.8
 83.3 ± 52.7
 98.5 ± 37.5
 64 ± 31.1
TRG/HDL-C ratio 2.1 ± 0.8 3 ± 1.5 2.5 ± 1 2.4 ± 0.5 1.7 ± 1.2 2.9 ± 2.2 1.9 ± 1.3 2.2 ± 0.9 2 ± 0.8

Data are expressed as mean ± SDS. SDS denotes the standard-deviation score for age and sex.

After Tx, after treatment; CA, Chronological age; BMI, body mass index; Ob/Over, obesity and overweight rate; Total-C, total cholesterol; LDL-C, Low density lipoprotein cholesterol; HDL-C, High density lipoprotein cholesterol; TGR, Triglycerides.

*p 0.02, treated vs. untreated at 3 years of follow up.